Alnylam Pharmaceuticals Inc

ALNY

Equity

ISIN null / Valor 1806798

NASDAQ (2026-02-25)

USD 327.36-1.65%

Alnylam Pharmaceuticals Inc
UMushroom community rating:

3.00 1 votes No rating yet

NegativeNeutralPositive

About company

Alnylam Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing RNAi therapeutics for diseases with high unmet medical needs. Their robust pipeline includes investigational treatments for genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system and ocular diseases. With more than a dozen RNAi therapeutics in clinical development, including multiple in late-stage development, Alnylam is dedicated to advancing innovative treatments to address significant health challenges.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

33.5%1Y

72.5%3Y

123%5Y

Performance

42.7%1Y

42.9%3Y

47.2%5Y

Volatility

43416 M

Market cap (USD)

751,722

Daily traded volume (Shares)

236.59 / 233.29

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.00

1 votes

Performance:

3.00

Innovation:

4.00

Society:

4.00

Nature:

3.00

X Q

Switzerland, 28 Mar 2025

Für das aktuelle Geschäftsjahr erwarten Analysten einen Zuwachs des Gewinns um 1.762,5%. Insgesamt spricht die unzuverlässige Gewinnentwicklung für ein unsicheres Investment mit erhöhtem Risiko.

EQUITIES OF THE SAME SECTOR

Integra Lifesciences Holdings Corp

Integra Lifesciences Holdings Corp Valor: 912247

Annual Return

-50%0%+50%

Risk level

110

0.52%USD 11.59

ICU Medical Inc

ICU Medical Inc Valor: 940704

Annual Return

-50%0%+50%

Risk level

110

1.74%USD 155.12

CRISPR Therapeutics Ltd

CRISPR Therapeutics Ltd Valor: 33408113

Annual Return

-50%0%+50%

Risk level

110

-2.77%USD 55.20

Merit Medical Systems Inc

Merit Medical Systems Inc Valor: 951136

Annual Return

-50%0%+50%

Risk level

110

-3.88%USD 79.23

Lantheus Holdings Inc

Lantheus Holdings Inc Valor: 24784644

Annual Return

-50%0%+50%

Risk level

110

2.87%USD 75.72

Arrowhead Pharmaceuticals Inc

Arrowhead Pharmaceuticals Inc Valor: 32193461

Annual Return

-50%0%+50%

Risk level

110

-3.23%USD 61.62

Interparfums Inc

Interparfums Inc Valor: 833467

Annual Return

-50%0%+50%

Risk level

110

-1.32%USD 101.61

Progyny Inc

Progyny Inc Valor: 50342281

Annual Return

-50%0%+50%

Risk level

110

2.65%USD 21.33

AMEDISYS Inc

AMEDISYS Inc Valor: 399513

Annual Return

-50%0%+50%

Risk level

110

0.00%USD 100.99

LivaNova PLC

LivaNova PLC Valor: 28726218

Annual Return

-50%0%+50%

Risk level

110

1.80%USD 70.29

Logos provided by Clearbit

Alnylam Pharmaceuticals Inc

ALNY

ISIN null / Valor 1806798

Alnylam Pharmaceuticals Inc UMushroom community rating:

X Q

Alnylam Pharmaceuticals Inc
UMushroom community rating: